89bio
Phase 1Clinical-stage biopharmaceutical company dedicated to developing and delivering innovative therapies to treat people with liver and cardiometabolic diseases.
Founded
2018
Focus
Biologics
About
Clinical-stage biopharmaceutical company dedicated to developing and delivering innovative therapies to treat people with liver and cardiometabolic diseases.
Funding History
8Total raised: $786M
PIPE$150MRA Capital ManagementJun 15, 2021
PIPE$150MRA Capital ManagementFeb 15, 2021
IPO$120MUndisclosedNov 7, 2019
IPO$126MUndisclosedNov 7, 2019
Company Info
TypePrivate
Founded2018
LocationSan Francisco, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile